Zetia and Bleeding disorders - a phase IV clinical study of FDA data

Summary:

Bleeding disorders is reported as a side effect among people who take Zetia (ezetimibe), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Pradaxa, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Bleeding disorders when taking Zetia. It is created by eHealthMe based on reports of 47,765 people who have side effects when taking Zetia from the FDA, and is updated regularly.

What is Zetia?

Zetia has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 49,113 Zetia users. Check the latest studies of Zetia.

What is Bleeding disorders?

Bleeding disorders is found to be associated with 1,190 drugs and 1,649 conditions by eHealthMe. Check the latest studies of Bleeding disorders.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

47,765 people reported to have side effects when taking Zetia.
Among them, 81 people (0.17%) have Bleeding disorders.

Among these 81 people:

How long have people been on Zetia when they have Bleeding disorders? *

What is the gender of people who have Bleeding disorders when taking Zetia? *

female: 58.97 %
male: 41.03 %

What is the age of people who have Bleeding disorders when taking Zetia? *

What are other drugs people take besides Zetia? *

What are other side effects people have besides Bleeding disorders? *

Acute Kidney Failure: 17 people, 20.99%
Fatigue (feeling of tiredness): 16 people, 19.75%
Dyspnea (difficult or laboured breathing): 15 people, 18.52%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 14 people, 17.28%
Fall: 14 people, 17.28%
Weakness: 13 people, 16.05%
Pain: 13 people, 16.05%
Rashes (redness): 13 people, 16.05%
Chest Pain: 13 people, 16.05%
International Normalised Ratio Increased: 12 people, 14.81%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 25 people, 30.86%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 8.64%
Diabetes: 6 people, 7.41%
Pain: 5 people, 6.17%
Type 2 Diabetes: 5 people, 6.17%
Depression: 5 people, 6.17%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 4.94%
Constipation: 4 people, 4.94%
Cardiac Disorder: 4 people, 4.94%
Hypersensitivity: 4 people, 4.94%

* Approximation only. Some reports may have incomplete information.

Do you take Zetia and have Bleeding disorders?

- Check whether Bleeding disorders is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zetia:

Zetia (49,113 reports)

Browse all side effects of Zetia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding disorders:

Bleeding disorders (1,190 drugs)

Browse all the conditions that are associated with Bleeding disorders:

Bleeding disorders (1,649 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe (the active ingredients of Zetia) and Zetia (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.